Blocking leukotrienes optimize asthma control: The BLOC survey | Zendy

MajdyM. Idrees | Zendy; MohamedS Al Moamary | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Blocking leukotrienes optimize asthma control: The BLOC survey

Author(s) -

MajdyM. Idrees,

MohamedS Al Moamary

Publication year - 2007

Publication title -

annals of thoracic medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.639

H-Index - 33

eISSN - 1817-1737

pISSN - 1998-3557

DOI - 10.4103/1817-1737.33696

Subject(s) - montelukast , medicine , asthma , bronchodilator , corticosteroid , leukotriene , pediatrics , population , anesthesia , leukotriene receptor , environmental health

The aim of this study was to evaluate asthma control after the introduction of a leukotriene modifier (Montelukast), in addition to the current controller asthma therapies, in patients with inadequately controlled mild-to-moderate persistent asthma. Asthma control and patient perception were assessed prior to, and 4 weeks after, the introduction of Montelukast, and the pre-introduction and post-introduction results were compared.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research